Blueprint for EECA countries, first edition
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Doc. No.: INS/GDL/001-(Annexes)
Training materials for healthcare workers
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 5-11 November 2017 and includes updates on measles, rubella, chikungunya, West Nile virus, Plague, monkeypox, legionnair...es's disease, influenza and Marburg virus disease.
more
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidance
Second Edition
Monitoring and Evaluation